Target Selection. The Parties intend to initiate one or more Research Programs, each focused on discovering, generating, identifying and characterizing (i) monospecific Antibodies Directed To a single Target (in the case of a Monospecific Research Program), or (ii) Bispecific Antibodies Directed To two Targets (in the case of a Bispecific Research Program) (each Target that is the subject of a Research Program, a “Selected Target”). As of the Effective Date, the Parties have agreed to the Research Programs and corresponding Selected Targets listed on Exhibit A. Additional Research Programs and corresponding Selected Targets may be added to this Agreement by mutual written agreement of the Parties, it being understood that each Party may accept or reject a new Research Program and corresponding Selected Target(s) in its sole discretion and no Party shall be obligated under this Agreement to agree to any further Research Programs and/or Selected Target(s).
Appears in 2 contracts
Sources: Antibody Discovery and Option Agreement (Galecto, Inc.), Antibody Discovery and Option Agreement (Galecto, Inc.)